Drug Side Effects
Search
SARCOMATOID CARCINOMA
SARCOMATOID CARCINOMA
was reported 58 times
SARCOMATOID CARCINOMA is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
Platinum-based Drug [EPC]
7
0.0000
1
Polyene Antifungal [EPC]
1
0.0000
2
Integrin Receptor Antagonist [EPC]
2
0.0000
3
CTLA-4-directed Blocking Antibody [EPC]
1
0.0000
4
Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]
1
0.0000
5
Aromatase Inhibitor [EPC]
2
0.0000
6
Vascular Endothelial Growth Factor Inhibitor [EPC]
3
0.0000
7
Kinase Inhibitor [EPC]
9
0.0000
8
BCL-2 Inhibitor [EPC]
1
0.0000
9
Folate Analog Metabolic Inhibitor [EPC]
6
0.0000
10
Androgen Receptor Inhibitor [EPC]
1
0.0000
11
Microtubule Inhibitor [EPC]
2
0.0000
12
Nucleoside Analog Antiviral [EPC]
1
0.0000
13
Programmed Death Receptor-1 Blocking Antibody [EPC]
1
0.0000
14
Interleukin-12 Antagonist [EPC]
1
0.0000
15
Interleukin-23 Antagonist [EPC]
1
0.0000
16
Benzodiazepine [EPC]
6
0.0000
17
Thalidomide Analog [EPC]
4
0.0000
18
Interleukin-6 Receptor Antagonist [EPC]
1
0.0000
19
alpha-Adrenergic Blocker [EPC]
1
0.0000
20
beta-Adrenergic Blocker [EPC]
2
0.0000
21
Angiotensin 2 Receptor Blocker [EPC]
2
0.0000
22
Xanthine Oxidase Inhibitor [EPC]
1
0.0000
23
Corticosteroid [EPC]
7
0.0000
24
Nucleoside Metabolic Inhibitor [EPC]
1
0.0000
25
CD20-directed Cytolytic Antibody [EPC]
1
0.0000
26
Tumor Necrosis Factor Blocker [EPC]
3
0.0000
27
HMG-CoA Reductase Inhibitor [EPC]
1
0.0000
28
Proton Pump Inhibitor [EPC]
1
0.0000